Express Scripts Holding Company Buyback
OLI recorded this information on 2/25/2016
Company: |
Express Scripts Holding Company |
Buyback: |
ESRX buyback |
Share Amount Authorized: |
32,100,000 |
Buyback Details: |
Express Scripts Holding Company (Nasdaq: ESRX) (the "Company or "Express Scripts") announced that it has entered into an accelerated share repurchase (ASR) agreement with Morgan Stanley & Co. LLC. Under the terms of the ASR agreement the Company will receive an aggregate initial delivery of approximately 32.1 million shares of the Company's common stock in exchange for a prepayment of $2.8 billion. The final number of shares to be repurchased will be based on the average of the daily volume-weighted average prices of the Company's common stock during the term of the transaction, less a discount and subject to adjustments pursuant to the terms and conditions of the ASR agreement (including a cap on the price paid per share by the Company in the event of a substantial increase in the volume-weighted average price of the Company's common stock during the term of the transaction). At settlement, under certain circumstances, Morgan Stanley may be required to deliver additional shares of common stock to the Company, or under certain circumstances, the Company may be required to deliver shares of common stock or to make a cash payment, at its election, to Morgan Stanley. The final settlement of the transaction under the ASR agreement is expected to occur during the third quarter of 2016. |
Express Scripts Holding is a pharmacy benefit management (PBM) company. Co. has two reportable segments: PBM, which consists of clinical solutions, Express Scripts SafeGuardRx®, specialized pharmacy care, home delivery pharmacy services, specialty pharmacy services, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, Medicare, Medicaid and Public Exchange offerings, administration of a group purchasing organization, Inside Rxsm and digital consumer health and drug information; and Other Business Operations, which consists of provider services and medical benefitmanagement services.
Open the ESRX Page at The Online Investor »
Open the ESRX Page at The Online Investor (in a new window) »